Ready to submit? Start a new submission or continue a submission in progress
Go to submission site (link opens in a new window)Journal overview
The journal will prioritise preclinical and clinical studies on immunotherapy of disorders such as chronic inflammation, allergy, autoimmunity, cancer etc. The effects of small-drugs, vaccines and biologics against central immunological targets as well as cell-based therapy, including dendritic cell therapy, T cell adoptive transfer and stem cell therapy, are topics of particular interest. Publications pointing towards potential new drug targets within the immune system or novel technology for immunopharmacological drug development are also welcome.
With an immunoscience focus on drug development, immunotherapy and toxicology, the journal will cover areas such as infection, allergy, inflammation, tumor immunology, degenerative disorders, immunodeficiencies, neurology, atherosclerosis and more.
Immunopharmacology and Immunotoxicology will accept original manuscripts, brief communications, commentaries, mini-reviews, reviews, clinical trials and clinical cases, on the condition that the results reported are based on original, clinical, or basic research that has not been published elsewhere in any journal in any language (except in abstract form relating to paper communicated to scientific meetings and symposiums).
Authors can choose to publish gold open access in this journal.
Read the Instructions for Authors for information on how to submit your article.
Explore articles
Explore the most recently published articles
Latest issues
Previous issue
Advertise in this journal
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Immunopharmacology and Immunotoxicology.